Massive cancer databank aims to personalize treatment
NCT ID NCT05061342
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is creating a large databank of blood, imaging, and tissue samples from 5,000 cancer patients. Researchers will track how patients respond to various treatments—including surgery, radiation, and chemotherapy—and look for biomarkers that predict tumor control, side effects, and quality of life. The goal is to better understand which treatments work best for which patients, but this is an observational study, not a test of a new therapy.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this databank could help doctors predict which cancer treatments work best for each patient, improving personalized care.
What could go wrong
This is an observational study, not a treatment trial. It collects data but does not test any new drug or therapy, so it won't directly change patient care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
UHongKongShenzhen
RECRUITINGShenzhen, Guangdong, China
Contact Phone: •••-•••-•••• Email: •••••@•••••